Treatment of hypertrophic and keloid scars with SILASTIC Gel Sheeting.
An evaluation of the results of treatment of both fresh and long-standing hypertrophic and keloid scars on the lower extremities using topical SILASTIC Gel Sheeting was performed in 94 patients ranging in age from 11 to 73 years. In the total of 94 patients, there were 80 with true hypertrophic scars. Of this group, 74 patients (92.5%) were greatly improved with treatment, five patients (6.25%) were somewhat improved, and one patient (1.25%) was not improved. The remaining 14 patients in the study had true keloid scars, and their results were poorer with five patients (35.7%) greatly improved, five patients (35.7%) somewhat improved, and four patients (28.6%) showing no improvement. When all patients were totalled together, there were 79 patients (84%) greatly improved, 10 patients (11%) somewhat improved, and only five patients (5%) with no improvements. Overall, the success rate (somewhat improved to greatly improved) for the treatment of hypertrophic and keloid scars is high (95%).
Dockery
G L
GL
Department of Podiatric Surgery, Waldo Podiatric Residency Program, Fifth Avenue Hospital, Seattle, Washington.
Nilson
R Z
RZ
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D017439:Cicatrix, Hypertrophic / Q000628:therapy*; D004129:Dimethylpolysiloxanes / Q000627:therapeutic use*; D005260:Female; D005528:Foot / Q000601:surgery; D018409:Foot Injuries; D006801:Humans; D007627:Keloid / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings; D012826:Silicone Elastomers / Q000627:therapeutic use*; D013526:Surgical Mesh
D004129:Dimethylpolysiloxanes; D012826:Silicone Elastomers